News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current CVSGF market cap is 865.43M. The company's latest EPS is GBP 0.5843 and P/E is 19.85.
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 406.5M | 427.8M | 510.1M | 554.2M | 608.3M |
| Operating Income | 16.4M | 21M | 40.8M | 42.8M | 62.3M |
| Net Income | 8.2M | 5.7M | 19.3M | 25.7M | 41.9M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 377.4M | 464.3M | 484.5M | 518.2M | 572.3M |
| Total Liabilities | 214.3M | 297.7M | 293.4M | 300.8M | 315.7M |
| Total Equity | 163.1M | 166.6M | 191.1M | 217.4M | 256.6M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | 41.4M | 77.6M | 60.2M | 75.5M | 84.5M |
| Investing | -69.5M | -19.6M | -35.4M | -45.1M | -99.9M |
| Financing | 25.6M | -49M | -12.6M | -15.1M | -12.1M |
| Market Cap | 865.43M |
| Price to Earnings Ratio | 19.85 |
| Price to Sales Ratio | 1.37 |
| Price to Cash Ratio | 38.69 |
| Price to Book Ratio | 3.24 |
| Dividend Yield | - |
| Shares Outstanding | 71.71M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -36.45% |
| 52 Week High | 19.94 |
| 52 Week Low | 11.50 |
| Spread (Intraday) | 2.14 (13.54%) |
| Company Name | CVS Group PLC (PK) |
| Address |
cvs house norfolk IP22 4ER |
| Website | https://www.cvsukltd.co.uk |
| Industry | veterinary svcs-animal specs (0742) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
![Logo of Glaxe [Project Galaxy] (GALETH).](/common/images/company/COIN_GALUSD.png){kind=small}
